rly-4008
relay therapeutics
['nct04526106', 'rly-4008']
rly-4008 is a highly selective fgfr2i that targets primary alterations and resistance mutations and induces tumor regression while sparing other fgfrs, suggesting it may have broad therapeutic potential. nct04526106
#asco23 
🇭🇷🇺🇸